Gene · 8726
Papers3,114
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,114
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets. | EBioMedicine | 2023 | 37837931 | PubTator, text mining | PubMed |
| Polycomb repressive complex 2 regulates basal cell fate during adult olfactory neurogenesis. | Stem Cell Reports | 2023 | 37832538 | PubTator, text mining | PubMed |
| Aging and Age-Related Epigenetic Drift in the Pathogenesis of Leukemia and Lymphomas: New Therapeutic Targets. | Cells | 2023 | 37830606 | PubTator, text mining | PubMed |
| Derepressing of STAT3 and USP7 contributes to resistance of DLBCL to EZH2 inhibition. | Heliyon | 2023 | 37829803 | PubTator, text mining | PubMed |
| ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance. | Nucleic Acids Res | 2023 | 37823600 | PubTator, text mining | PubMed |
| MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression. | Commun Biol | 2023 | 37821650 | PubTator, text mining | PubMed |
| Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis. | Acta Neuropathol | 2023 | 37821623 | PubTator, text mining | PubMed |
| PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression. | Cancer Cell Int | 2023 | 37807067 | PubTator, text mining | PubMed |
| Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner. | BMC Cancer | 2023 | 37803297 | PubTator, text mining | PubMed |
| Host genetics and gut microbiota jointly regulate blood biochemical indicators in chickens. | Appl Microbiol Biotechnol | 2023 | 37792060 | PubTator, text mining | PubMed |
| The bidirectional interplay between ncRNAs and methylation modifications in gastrointestinal tumors. | Int J Biol Sci | 2023 | 37781524 | PubTator, text mining | PubMed |
| Coevolution of the CDCA7-HELLS ICF-related nucleosome remodeling complex and DNA methyltransferases. | Elife | 2023 | 37769127 | PubTator, text mining | PubMed |
| Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy. | Int J Mol Sci | 2023 | 37762249 | PubTator, text mining | PubMed |
| β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy. | Front Immunol | 2023 | 37744383 | PubTator, text mining | PubMed |
| STPP-UP: An alternative method for drug target identification using protein thermal stability. | J Biol Chem | 2023 | 37742922 | PubTator, text mining | PubMed |
| Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability. | Nat Struct Mol Biol | 2023 | 37735617 | PubTator, text mining | PubMed |
| Protein Kinase Signaling Networks Driven by Oncogenic Gq/11 in Uveal Melanoma Identified by Phosphoproteomic and Bioinformatic Analyses. | Mol Cell Proteomics | 2023 | 37730182 | PubTator, text mining | PubMed |
| CBX4 promotes antitumor immunity by suppressing Pdcd1 expression in T cells. | Mol Oncol | 2023 | 37691307 | PubTator, text mining | PubMed |
| EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis. | Cancer Cell Int | 2023 | 37689710 | PubTator, text mining | PubMed |
| Imprinted Long Non-Coding RNAs in Mammalian Development and Disease. | Int J Mol Sci | 2023 | 37686455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8726/papers?page=10